Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2026

NCT07603869 | Completed

• 1 other identifier: EAPC-CVRISK 2026
• Study Type: observational
• Target: 511
• Locations: 1 country
• Sites: 1

Brief Summary

The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens. In line with this call for public health diagnosis of CV health, the ESC, through the European Association of Preventive Cardiology (EAPC), is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Preventive Cardiology Congress 2026 from 23-24 April 2026 in Ljubljana, Slovenia. The primary objective of the study is to screen the CV risk among the ESC Annual Congress 2026 attendees with a focus on healthcare professionals (HCP) and to stratify by primary or secondary prevention.

Conditions

Cardiovascular Risks

Outcome Measures

Primary Outcomes (2)

• Second Manifestations or Arterial Disease (SMART) algorithm in patients with established CVD

  At time of visit

• Systemic Coronary Risk Evaluation 2 (SCORE2) algorithm in patients without established CVD

  At time of visit

Interventions

Questionnaire and Physical Exam BEHAVIORAL

Questionnaire EQ-5D-5L with some lifestyle habits and medical history

blood draw BIOLOGICAL

Blood draw

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All adults attendees (including healthcare professional) attending the EAPC Congress 2026 from 23 and 24 April in Ljubljana

You may qualify if:

• All attendees including healthcare professionals (doctors, nurses, etc.) attending the EAPC Congress 2026 from 23 to 24 April 2026
• Subjects who declare that they are able to understand and give IC in English

You may not qualify if:

• Subjects not willing to provide his/her consent to participate in the study.
• Subjects who are not suitable candidates for blood extraction.

Sponsors & Collaborators

• European Society of Cardiology: lead

Study Sites (1)

Cankarjev Dom

Ljubljana, 1000, Slovenia

Location

MeSH Terms

Interventions

Surveys and Questionnaires; Restraint, Physical; Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health; Behavior Control; Therapeutics; Immobilization; Specimen Handling; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Punctures; Surgical Procedures, Operative

Study Officials

• Zlatko Fras

  Division of Medicine, Centre for Preventive Cardiology, University Medical Centre, Slovenia

  STUDY CHAIR

• Tim Kambič

  Department of Medical Sciences in Sport and Exercise, Faculty of Sport, University of Ljubljana, Slovenia

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: NETWORK
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 18, 2026
• First Posted: May 22, 2026
• Study Start: April 23, 2026
• Primary Completion: April 24, 2026
• Study Completion: April 24, 2026
• Last Updated: May 22, 2026

Record last verified: 2026-05

Locations

SL (1)